BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9259909)

  • 1. Fatal hepatic veno-occlusive disease in a newborn infant.
    Seibold-Weiger K; Vochem M; Mackensen-Haen S; Speer C
    Am J Perinatol; 1997 Feb; 14(2):107-11. PubMed ID: 9259909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Color-flow imaging sonography of portal and hepatic vein flow to monitor fibrinolytic therapy with r-TPA for veno-occlusive disease following myeloablative treatment.
    Sonneveld P; Laméris JS; Cornelissen J; Ogilvie A; Löwenberg B
    Bone Marrow Transplant; 1998 Apr; 21(7):731-4. PubMed ID: 9578316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Veno-occlusive disease (VOD) of the liver in Korean patients following allogeneic bone marrow transplantation (BMT): efficacy of recombinant human tissue plasminogen activator (rt-PA) treatment.
    Lee JH; Lee KH; Choi JS; Zang DY; Kim SB; Kim SW; Suh C; Lee JS; Kim WK; Lee YS; Kim SH
    J Korean Med Sci; 1996 Apr; 11(2):118-26. PubMed ID: 8835758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Veno-occlusive disease of the liver complicating ABMT successfully treated with recombinant tissue plasminogen activator (rt-PA).
    Baglin TP; Harper P; Marcus RE
    Bone Marrow Transplant; 1990 Jun; 5(6):439-41. PubMed ID: 2369685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of tissue plasminogen activator in the treatment of veno-occlusive liver disease after bone marrow transplantation.
    Terra SG; Spitzer TR; Tsunoda SM
    Pharmacotherapy; 1997; 17(5):929-37. PubMed ID: 9324182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of hepatic veno-occlusive disease after bone marrow transplantation with recombinant human tissue plasminogen activator (rh-tPA)].
    Yoshimi A; Kato K; Maeda N; Matsuyama T; Kojima S
    Rinsho Ketsueki; 2000 Feb; 41(2):103-8. PubMed ID: 10723238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hepatic venoocclusive disease with recombinant human tissue plasminogen activator or orthotopic liver transplantation after allogeneic bone marrow transplantation.
    Hágglund H; Ringdén O; Ericzon BG; Duraj F; Ljungman P; Lönnqvist B; Winiarski J; Tydén G
    Transplantation; 1996 Oct; 62(8):1076-80. PubMed ID: 8900305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human tissue plasminogen activator for the treatment of severe hepatic veno-occlusive disease in pediatric bone marrow transplant patients.
    Leahey AM; Bunin NJ
    Bone Marrow Transplant; 1996 Jun; 17(6):1101-4. PubMed ID: 8807121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective survey on incidence, risk factors and therapy of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation.
    Cesaro S; Pillon M; Talenti E; Toffolutti T; Calore E; Tridello G; Strugo L; Destro R; Gazzola MV; Varotto S; Errigo G; Carli M; Zanesco L; Messina C
    Haematologica; 2005 Oct; 90(10):1396-404. PubMed ID: 16219577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doppler sonography: a noninvasive method for evaluation of hepatic venocclusive disease.
    Brown BP; Abu-Yousef M; Farner R; LaBrecque D; Gingrich R
    AJR Am J Roentgenol; 1990 Apr; 154(4):721-4. PubMed ID: 2107664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Life-threatening veno-occlusive disease after living-related liver transplantation.
    Nakazawa Y; Chisuwa H; Mita A; Ikegami T; Hashikura Y; Terada M; Nakayama J; Kawasaki S
    Transplantation; 2003 Mar; 75(5):727-30. PubMed ID: 12640317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental model of hepatic venoocclusive disease (VOD) caused by dactinomycin--preliminary report about hepatoprotective effect of amifostine.
    Czauderna P; Chyczewski L; Lech K; Langner G; Bednarczuk G; Borowska H; Arciszewska E
    Med Sci Monit; 2000; 6(3):446-53. PubMed ID: 11208352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of fibrinolytic and clotting parameters in the diagnosis of liver veno-occlusive disease after hematopoietic stem cell transplantation in a pediatric population.
    Sartori MT; Spiezia L; Cesaro S; Messina C; Paris M; Pillon M; Saggiorato G; Pagnan A; Girolami A; Zanesco L; Cella G
    Thromb Haemost; 2005 Apr; 93(4):682-9. PubMed ID: 15841312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of reversed flow in segmental branches of the portal vein with hand-held color Doppler ultrasonography after hematopoietic stem cell transplantation.
    Hashiguchi M; Okamura T; Yoshimoto K; Ono N; Imamura R; Yakushiji K; Ogata H; Seki R; Otsubo K; Oku E; Kuroiwa M; Higuchi M; Kato K; Taniguchi S; Gondo H; Shibuya T; Nagafuji K; Harada M; Sata M
    Bone Marrow Transplant; 2005 Dec; 36(12):1071-5. PubMed ID: 16247437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of veno-occlusive disease complicated by severe hemorrhagic cystitis successfully treated with recombinant plasminogen activator.
    Arsène O; Delain M; Linassier C; Bremond JL; Colombat P
    Hematol Cell Ther; 1997 Aug; 39(4):205-7. PubMed ID: 9352329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The value of MSCT and MRI in the diagnosis of hepatic veno-occlusive disease].
    Pei YG; Hu DY; Shen YQ; Wang QX; Hu LW
    Zhonghua Gan Zang Bing Za Zhi; 2010 Feb; 18(2):150-2. PubMed ID: 20196959
    [No Abstract]   [Full Text] [Related]  

  • 17. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.
    Dignan FL; Wynn RF; Hadzic N; Karani J; Quaglia A; Pagliuca A; Veys P; Potter MN; ;
    Br J Haematol; 2013 Nov; 163(4):444-57. PubMed ID: 24102514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Portal vein thrombosis after hematopoietic cell transplantation: frequency, treatment and outcome.
    Kikuchi K; Rudolph R; Murakami C; Kowdley K; McDonald GB
    Bone Marrow Transplant; 2002 Feb; 29(4):329-33. PubMed ID: 11896430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombolytic treatment of portal thrombosis.
    Malkowski P; Pawlak J; Michalowicz B; Szczerban J; Wroblewski T; Leowska E; Krawczyk M
    Hepatogastroenterology; 2003; 50(54):2098-100. PubMed ID: 14696472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A light and scanning electron microscopic study of hepatic veno-occlusive disease.
    Shirai M; Nagashima K; Iwasaki S; Mori W
    Acta Pathol Jpn; 1987 Dec; 37(12):1961-71. PubMed ID: 3445752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.